Autosomal dominant spastic paraplegia in four generations of Yakut family linked to dynamin 2 mutation

The article presents the results of a clinical and genetic study of a Yakut family with hereditary spastic paraplegia (HSP). Patients with clinically diagnosed HSP and healthy family members were studied. The disease is clinically characterized as a progressive spastic paraplegia of the lower extremities concomitant peripheral neuropathy in advanced case. The methods of exome sequencing of the entire genome, molecular modeling of dynamin-2 and experimental reproduction of key elements of the HSP pathogenesis have been applied. Genetic analysis revealed a novel missense c.2155C> T, p.R719W mutation in the highly conserved GTP-effector domain of the dynamin-2 gene (DNM2). In experiments on HeLa cells, it was shown that mutant dynamin-2 affected endocytosis process. In-silico modeling determined that the identified mutation is located in the DNM2 bundle-signaling element and potentially disrupts the assembly and functional properties of the protein. Testing of this mutation in other Yakut families with HSP showed a negative result, which once again confirms the genetic heterogeneity of this pathology.

1. Nikolaeva T.Ya. The dynamics of the spectrum of hereditary diseases of the nervous system in the Republic of Sakha (Yakutia). / T.Ya. Nikolaeva, T.E. Popova, Z.M. Kuzmina //The problem of Viliuisk encephalomyelitis and degenerative brain diseases in Yakutia. Abstracts of the IV International Scientific and Practical Conference. August 24-26, 2011. Yakutsk. - P. 65-67.

2. A dynamin mutant defines a superconstricted prefission state / AC Sundborger, S Fang, JA Heymann, et.al. // Cell Rep. – 2014. – 8. – P. 734-742. doi: 10.1016/j.celrep.2014.06.054.

3. A pseudoatomic model of the dynamin polymer identifies a hydrolysis-dependent power-stroke. / JS Chappie, JA Mears, S Fang, et.al. // Cell. – 2011. – 147. – P. 209–222. doi: 10.1016/j.cell.2011.09.003.

4. Analysis of DNA sequence variants detected by high-throughput sequencing / DR Adams, M. Sincan, K. Fuentes Fajardo, et al. // Hum Mutat. – 2012. – 33. - P. 599-608. doi: 10.1002/humu.22035

5. Blackstone C. Cellular pathways of hereditary spastic paraplegia / C. Blackstone // Annu Rev Neurosci. – 2012. – 35. – P. 25-47. doi: 10.1146/annurev-neuro-062111-150400

6. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy / D Fischer, M Herasse, M Bitoun, et.al. // Brain. – 2006. – 129. – P. 1463-1469. DOI: 10.1093/brain/awl071

7. Crystal structure of nucleotide-free dynamin / K Faelber, Y Posor, S Gao , et.al. // Nature. – 2011. – 477. – P. 556-560. doi: 10.1038/nature10369.

8. Domain structure and intramolecular regulation of dynamin GTPase / A.B. Muhlberg, D.E. Warnock, S.L. Schmid // EMBO J. – 1997. – 16. – P. 6676-6683. DOI: 10.1093/emboj/16.22.6676

9. Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis. / M. Bitoun, AC Durieux, B Prudhon, et.al. // Hum Mutat. - 2009. – 30. – P. 1419–1427. doi: 10.1002/humu.21086.

10. Fink J.K. Hereditary spastic paraplegia: clinical principles and genetic advances / J.K. Fink // Semin Neurol. – 2014. – 34. – P. 293-305. doi: 10.1055/s-0034-1386767

11. G domain dimerization controls dynamin’s assembly-stimulated GTPase activity. / JS Chappie, S Acharya, M Leonard, et.al. // Nature. – 2010. – 465. – P. 435–440. doi: 10.1038/nature09032

12. I-TASSER: a unified platform for automated protein structure and function prediction. / A Roy, A Kucukural, Y Zhang // Nature Protocols. – 2010. – 5. – P. 725-738. doi: 10.1038/nprot.2010.5.

13. Kenniston J.A., Lemmon M.A. Dynamin GTPase regulation is altered by PH domain mutations found in centronuclear myopathy patients / J.A. Kenniston, M.A. Lemmon // EMBO J. – 2010. – 29. – P.3054–3067. doi: 10.1038/emboj.2010.187.

14. Mild functional differences of dynamin 2 mutations associated to Centronuclaer myopathy and Charcot-Marie-Tooth peripheral neuropathy / OS Koutspoulos, C Koch, V Tosch, et.al. // PloS One. – 2011. – 6. - e277498. doi: 10.1371/journal.pone.0027498.

15. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement / J Schessl , L Medne , Y Hu, et.al. // Neuromuscul Disord. – 2007. – 17. –P.28-32. DOI: 10.1016/j.nmd.2006.09.013

16. Mutations in dynamin 2 cause dominant centronuclear myopathy / M. Bitoun, S. Maugenre, PY Jeannet, et. al. //Nat Genet. – 2005. – 37. - P. 1207–1209. DOI: 10.1038/ng1657

17. Neumann S. Dual role of BAR domaincontaining proteins in regulating vesicle release catalyzed by the GTPase, dynamin-2 / S. Neumann, S.L. Schmid // J Biol Chem. – 2013. – 288. – P. 25119-25128. doi: 10.1074/jbc.M113.490474

18. Overlapping molecular pathological themes link Charcot-Marie-Tooth neuropathies and hereditary spastic paraplegias / V Timmerman, VE Clowes, E Reid // Exp Neurol. – 2013. – 246. – P.14-25. doi: 10.1016/j.expneurol.2012.01.010.

19. Overlapping role of dynamin isoforms in synaptic vesicle endocytosis./ A Raimondi, SM Ferguson, X Lou, et.al. // Neuron. – 2011. – 70. – P.1100-1114. doi: 10.1016/j.neuron.2011.04.031

20. Pharmacologic rescue of axon growth defects in a human iPSC model of hereditary spastic paraplegia SPG3A / PP Zhu, KR Denton, TM Pierson, et.al. // Hum Mol Genet. – 2014. – 23. – P. 5638-5648. doi: 10.1093/hmg/ddu280.

21. Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy / KG Claeys, S Züchner, M Kennerson, et.al. // Brain. – 2009. – 132. – P. 1741-1752. doi: 10.1093/brain/awp115

22. Praefcke G.J. The dynamin superfamily: universal membrane abulation and fission molecules? / GJ Praefcke, HT McMahon // Nature Rev Mol Cell Biol. – 2004. – 5. – P. 133-147. DOI: 10.1038/nrm1313

23. Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm / P. Kumar, S. Henikoff , P.C. Ng // Nat Protoc. – 2009. – 4. – P.1073-1081. doi: 10.1038/nprot.2009.86.

24. Romero N.B. Centronuclear myopathies / N.B. Romero, M. Bitoun // Semin Pediatr Neurol. – 2011. – 18. – P.250-256. doi: 10.1016/j.spen.2011.10.006.

25. The I-TASSER Suite: Protein structure and function prediction / J Yang , R Yan , A Roy, et.al. // Nature Methods. – 2015. – 12. – P. 7-8. doi: 10.1038/nmeth.3213.

26. The phenotype of “pure” autosomal dominant spastic paraplegia / A Durr, A Brice, M Serdaru, et.al. // Neurology. – 1994. – 44. – P. 1274–1277. DOI: 10.1212/wnl.44.7.1274

27. Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease / GM Fabrizi, M Ferrarini, T Cavallaro, et.al. // Neurology. – 2007. – 69. – P. 291-295. DOI: 10.1212/01.wnl.0000265820.51075.61

28. UCSF Chimera—a visualization system for exploratory research and analysis / E.F. Pettersen, T.D. Goddard, C.C. Huang, et.al. // J Comput Chem. – 2004. – 25. – P. 1605–1612. DOI: 10.1002/jcc.20084

29. Zhang Y. I-TASSER server for protein 3D structure prediction / Y. Zhang // BMC Bioinformatics. – 2008. – 9. - 40. doi: 10.1186/1471-2105-9-40.